Olanzapine: is it enough for CINV prevention?

Ann Palliat Med. 2020 Jul;9(4):2427-2429. doi: 10.21037/apm-20-1018. Epub 2020 May 18.

Authors

Piyawan Tienchaiananda¹, Wipada Nipondhkit², Naiyarat Prasongsook³

Affiliations

¹ Oncology Unit, Department of Medicine, Rajavithi Hospital, Bangkok, Thailand. pt_kuk@hotmail.com.
² Chemotherapy Department, Udonthani Cancer Hospital, Udonthani, Thailand.
³ Medical Oncology Unit, Department of Medicine, Phramongkutklao Hospital, Bangkok, Thailand.

PMID: 32434367
DOI: 10.21037/apm-20-1018

No abstract available

MeSH terms

Antiemetics* / therapeutic use
Antineoplastic Agents* / therapeutic use
Benzodiazepines / therapeutic use
Humans
Nausea / chemically induced
Nausea / drug therapy
Nausea / prevention & control
Olanzapine* / therapeutic use
Vomiting / chemically induced
Vomiting / drug therapy
Vomiting / prevention & control

Substances

Antiemetics
Antineoplastic Agents
Benzodiazepines
Olanzapine